U.S. Federal Circuit Court of Appeals Rules in Favor of Regeneron and Sanofi in Praluent® (alirocumab) Patent Litigation

Go back to U.S. Federal Circuit Court of Appeals Rules in Favor of Regeneron and Sanofi in Praluent® (alirocumab) Patent Litigation
Regeneron (NASDAQ: REGN) Delayed: 516.62 -0.55 (0.11%)
Previous Close $517.17    52 Week High $592.36 
Open $520.00    52 Week Low $325.35 
Day High $521.13    P/E 135.60 
Day Low $512.25    EPS $3.81 
Volume 785,730